세계 폐암 수술 시장 : 제품 유형별, 수술 유형별, 수술식별, 암 스테이지별, 최종 사용자별, 지역별
Lung Cancer Surgery Market, By Product Type, By Surgery Type, By Procedure, By Cancer Stage, By End user, By Geography
상품코드
:
1392043
리서치사
:
Coherent Market Insights
발행일
:
2023년 11월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 폐암 수술 시장 규모는 2023년에 60억 6,000만 달러로 평가되었고, 2030년에는 82억 5,000만 달러에 이를 것으로 예측되며 2023년부터 2030년까지 복합 연간 성장률(CAGR) 4.5%를 나타낼 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2022년 |
2023년 시장 규모 |
60억 6,000만 달러 |
| 업적 데이터 |
2018-2021년 |
예측 기간 |
2023년-2030년 |
| 예측 기간의 복합 연간 성장률(CAGR) |
4.50% |
2030년 시장 규모 예측 |
82억 5,000만 달러 |
그림 1. 세계 폐암 수술 시장 점유율(%), 지역별, 2023년
폐암은 폐에서 발생하는 암의 일종입니다. 폐는 흉부에 있는 2개의 스펀지 모양의 기관으로, 사람이 숨을 들이마시면 산소를 흡수하고 구토할 때 이산화탄소를 방출합니다. 폐암은 세계에서 가장 흔한 암 중 하나이며 암으로 인한 사망의 주요 원인입니다.
폐암 수술은 암에 걸린 종양과 폐의 일부를 제거하기 위해 수행되는 의료 치료입니다. 수술의 유형은 폐 종양의 크기와 위치, 폐암의 유형(비소세포 폐암 또는 소세포 폐암), 환자의 전신 상태에 따라 달라집니다. 폐암 수술에는 폐엽절제술, 폐분절절제술 등 여러 유형가 있습니다. 폐암 수술은이 공격적인 질병을 치료하는 매우 중요한 접근법입니다. 병에 걸린 폐 조직을 외과적으로 절제함으로써, 의료 전문가는 제한된 종양을 쏘고 효과적인 치료와 치유의 가능성을 제공할 수 있습니다. 이 수술이 성공하는지 여부는 조기 발견, 정확한 병기 분류 및 환자의 전신 상태에 달려 있습니다. 전통적인 개복 수술부터 VATS(비디오 지원 흉강경 수술)와 같은 저침습 기술에 이르기까지 폐암 수술은 외상을 최소화하고 회복을 높이기 위해 진화해 왔습니다. 폐암 수술은 폐암에 대한 집학적 투쟁에서 매우 중요한 요소로 계속되고 있습니다.
시장 역학:
폐암의 유병률 증가는 예측 기간에 있어서 세계 폐암 수술 시장의 성장을 가속할 것으로 예상됩니다. 예를 들어, 세계암 연구기금 인터내셔널이 2022년 3월에 발표한 데이터에 따르면, 세계 전체에서는 2020년에 220만명 이상의 폐암 신규 환자가 발생하고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계 폐암 수술 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023년-2030년) 시장 규모와 복합 연간 성장률(CAGR)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시와 승인, 시장동향, 지역별 전망, 주요기업이 채용하는 경쟁전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 바탕으로 세계 폐암 수술 시장의 주요 기업을 프로파일링합니다.
- 이 보고서를 통해 인사이트을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계 폐암 수술 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 폐암 수술 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 폐암의 이환율 증가
- 폐암 수술의 고가의 비용
- 저침습 기술의 채용
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
제4장 세계 폐암 수술 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향
- 신형 코로나 바이러스 감염증(COVID-19)의 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계 폐암 수술 시장 : 제품 유형별(2018년-2030년)
- 소개
- 수술기구
- 감시 및 가시화 시스템
- 내시경 수술용 기기
- 로봇 지원 흉부 수술 시스템
- 기타
제6장 세계 폐암 수술 시장 : 수술 유형별(2018년-2030년)
제7장 세계 폐암 수술 시장 : 술식별(2018년-2030년)
- 소개
- 폐엽절제술
- 부분절제술/쐐기절제술
- 폐절제술
- 슬리브 절제
- 확대 절제
제8장 세계 폐암 수술 시장 : 암 스테이지별(2018년-2030년)
제9장 세계 폐암 수술 시장 : 최종 사용자별(2018년-2030년)
제10장 세계 폐암 수술 시장 : 지역별(2018년-2030년)
- 소개
- 북미
- 소개
- 미국
- 캐나다
- 유럽
- 소개
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 소개
- 중국
- 인도
- 일본
- ASEAN 국가
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 소개
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 중동
- 소개
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 소개
- 북아프리카
- 중앙 아프리카
- 남아프리카
제11장 경쟁 구도
- Ethicon(Johnson & Johnson)
- Medtronic
- Intuitive Surgical
- Olympus Corporation
- Karl Storz
- Accuray Incorporated
- AngioDynamics
- Varian Medical Systems
- Siemens Healthineers
- Atricure, Inc.
- Novadaq Technologies Inc.
- GE Healthcare
- Scanlan International Inc
제12장 섹션
BJH
영문 목차
The Global Lung Cancer Surgery Market size was valued at US$ 6.06 Bn in 2023 and is expected to reach US$ 8.25 Bn by 2030, grow at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030.
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 6.06 Bn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
4.50% |
2030 Value Projection: |
US$ 8.25 Bn |
Figure 1. Global Lung Cancer Surgery Market Share (%), By Region, 2023
Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.
Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure's success relies on early detection, accurate staging, and the patient's overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.
Market Dynamics:
The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.
Key features of the study:
- This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lung cancer surgery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lung cancer surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market
Global Lung Cancer Surgery Market Detailed Segmentation:
- By Product Type:
- Surgical Instruments
- Monitoring & Visualizing System
- Endosurgical Equipment
- Robotic-Assisted Thoracic Surgery Systems
- Others
- By Surgery Type:
- Open Surgery
- Minimally Invasive Surgery
- By Procedure:
- Lobectomy
- Segmentectomy/Wedge Resection
- Pneumonectomy
- Sleeve Resection
- Extended Resection
- By Cancer Stage:
- Early-Stage
- Advanced-Stage
- By End user:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- Ethicon (Johnson & Johnson)
- Medtronic
- Intuitive Surgical
- Olympus Corporation
- Karl Storz
- Accuray Incorporated
- AngioDynamics
- Varian Medical Systems
- Siemens Healthineers
- Atricure, Inc.
- Novadaq Technologies Inc.
- GE Healthcare
- Scanlan International Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Lung Cancer Surgery, By Surgery Type
- Market Lung Cancer Surgery, By Product Type
- Market Lung Cancer Surgery, By Procedure
- Market Lung Cancer Surgery, By Cancer Stage
- Market Lung Cancer Surgery, By End User
- Market Lung Cancer Surgery , By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of lung cancer
- High Cost of Lung Cancer Surgery
- Adoption of Minimally Invasive Techniques
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Lung Cancer Surgery Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Lung Cancer Surgery Market, By Product Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Monitoring & Visualizing System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Endosurgical Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Robotic-Assisted Thoracic Surgery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Lung Cancer Surgery Market, By Surgery Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Open Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Minimally Invasive Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Lung Cancer Surgery Market, By Procedure, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Lobectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Segmentectomy/Wedge Resection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Pneumonectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Sleeve Resection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Extended Resection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
8. Global Lung Cancer Surgery Market, By Cancer Stage, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Early-Stage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Advanced-Stage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Global Lung Cancer Surgery Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
10. Global Lung Cancer Surgery Market, By Geography, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Ethicon (Johnson & Johnson)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Intuitive Surgical
- Olympus Corporation
- Karl Storz
- Accuray Incorporated
- AngioDynamics
- Varian Medical Systems
- Siemens Healthineers
- Atricure, Inc.
- Novadaq Technologies Inc.
- GE Healthcare
- Scanlan International Inc
- Analyst Views
12. Section
- Research Methodology
- About us
관련자료
